IP Library › Granted Patent US 7,074,901
Granted Patent B2
US 7,074,901 · App. 09/924,340 · Granted Jul 11, 2006

Isolated human vCOL16A1 polypeptide and fragments thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,074,901
App. No.
09/924,340
Granted
Jul 11, 2006
Kind
B2
Abstract

The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.

Claims (7)

1. An isolated vCOL16A1 polypeptide comprising the amino acid sequence of SEQ ID NO: 58.

2. The polypeptide of claim 1 , wherein said polypeptide consists of the amino acid sequence of SEQ ID NO: 58.

3. A composition comprising the polypeptide of claim 1 and a physiologically acceptable carrier.

4. An isolated polypeptide comprising an amino acid sequence encoded by the human cDNA of deposited clone 625004 — 188-15-4-0-H6-F in ATCC accession number PTA-2534.

5. A composition comprising the polypeptide of claim 4 and a physiologically acceptable carrier.

6. A polypeptide fragment of SEQ ID NO: 58, wherein said fragment comprises at least 100 consecutive amino acids of SEQ ID NO:58.

7. A composition comprising the polypeptide of claim 6 and a physiologically acceptable carrier.